參考文獻 |
1. Hanayama, R., et al., Identification of a factor that links apoptotic cells to phagocytes. Nature, 2002. 417(6885): p. 182-7.
2. Dannenberg, A.M., Jr., Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated
macrophage enzymes. Bacteriol Rev, 1968. 32(2): p. 85-102.
3. Hirose, K., et al., Survival of Vi-capsulated and Vi-deleted Salmonella typhi strains in cultured macrophage expressing different levels of CD14 antigen. FEMS Microbiol
Lett, 1997. 147(2): p. 259-65.
4. Khazen, W., et al., Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett, 2005. 579(25): p. 5631-4.
5. Socinski, M.A., et al., Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo.
Blood, 1988. 72(2): p. 691-7.
6. M Stein, S.K., N Harris, S Gordon, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic
macrophage activation. . Journal of Experimental Medicine, 1992. 176: p. 287-292.
7. J., B., Arteriosclerosis, Thrombosis, and Vascular Biology Vol. 23. 2003.
8. Erwei Song, a., Nengtai Ouyang, Markus Hörbelta, Balazs Antusa, Minghui Wang, Michael S. Exton, Influence of Alternatively and Classically Activated Macrophages on Fibrogenic Activities of Human Fibroblasts. Cellular Immunology, 2000. 204: p. 19-28.
9. Rudensky, K.H.A.Y., Lysosomal cysteine proteases regulate antigen presentation. Nature Reviews Immunology 2003. 3: p. 472-482.
10. Clifford V Harding*, L.R.a.M.J.W., Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity. Current Opinion in Immunology, 2003. 15: p. 112-119.
11. Carlo Chizzolini, R.R., Carmelina De Luca, Danielle Burger, Jean-Michel Dayer Th2 Cell Membrane Factors in Association with IL-4 Enhance Matrix Metalloproteinase-1
(MMP-1) While Decreasing MMP-9 Production by Granulocyte-Macrophage Colony-Stimulating Factor-Differentiated Human Monocytes. The Journal of Immunology, 2000. 164: p. 5952-5960.
12. DUFFIELD, J.S., The inflammatory macrophage: a story of Jekyll and Hyde. Clinical Science 2003. 104: p. 27-38.
13. Gordon, S., Alternative activation of macrophages. Nature Reviews Immunology, 2003. 3: p. 23-35.
14. Ma, J., et al., Regulation of macrophage activation. Cell Mol Life Sci, 2003. 60(11): p. 2334-46.
15. Mosser, D.M., The many faces of macrophage activation. Journal of Leukocyte Biology, 2003. 73: p. 209-212.
16. CAO Bin, G.Z., ZHU Yuanjue,XU Wenbing, The potential role of PDGF, IGF-1, TGF-β expression in idiopathic pulmonary fibrosis. Chinese Medical Journal, 2000. 113: p. 776-782.
17. Ramesh, G. and W.B. Reeves, TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest, 2002. 110(6): p. 835-42.
18. Pai, R., et al., Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J Am Soc Nephrol, 1996. 7(6): p. 914-23.
19. Aqel, N.M., et al., Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J Pathol, 1985. 146(3): p. 197-204.
20. Beranek, J.T., Identification of macrophages in vessel allograft atherosclerosis. Transplantation, 1991. 52(4): p. 757.
21. Bjorneboe, G.E., [The role of lipoproteins and macrophages in the development of atherosclerosis]. Tidsskr Nor Laegeforen, 1989. 109(2): p. 216-9.
22. Daoud, A.S., et al., Role of macrophages in regression of atherosclerosis. Ann N Y Acad Sci, 1985. 454: p. 101-14.
23. Day, A.J., Lipid metabolism by macrophages and its relationship to atherosclerosis. Adv Lipid Res, 1967. 5: p. 185-207.
24. Koren, E., et al., Possible role of macrophages in regression of atherosclerosis. Prog Lipid Res, 1991. 30(2-3): p. 237-43.
25. Schaefer, H.E., The role of macrophages in atherosclerosis. Haematol Blood Transfus, 1981. 27: p. 137-42.
26. Watanabe, T., et al., Role of macrophages in atherosclerosis. Sequential observations of cholesterol-stimulated rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest, 1985. 53(1): p. 80-90.
27. Huang, S.S., et al., CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett, 2006. 580(26): p.
6259-68.
28. Banerji, S., et al., LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol, 1999. 144(4): p. 789-801.
29. Prevo, R., et al., Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem, 2001. 276(22): p. 19420-30.
30. Ji, R.C., Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol, 2006. 4(2): p. 83-100.
31. Huang, S.S., et al., Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1. J Biol Chem, 2003. 278(44): p. 43855-69.
32. Carmeliet, P., Angiogenesis in health and disease. Nat Med, 2003. 9(6): p. 653-60.
33. Cao, R., et al., PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell, 2004. 6(4): p. 333-45.
34. Boensch, C., et al., Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver
plasma membranes. J Biol Chem, 1995. 270(4): p. 1807-16.
35. Jeon, B.H., et al., Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res, 2008. 68(4): p. 1100-9.
36. Xu, H., et al., LYVE-1-positive macrophages are present in normal murine eyes. Invest Ophthalmol Vis Sci, 2007. 48(5): p. 2162-71.
37. Maruyama, K., et al., Inflammation-stimulated lymphangiogenesis in the cornea arises
from CD11b-positive macrophages. J Clin Invest, 2005. 115(9): p. 2363-72.
38. Schroedl, F., et al., The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive
macrophages. Invest Ophthalmol Vis Sci, 2008. 49(12): p. 5222-9.
39. Francey, T., et al., Culture of ovine bone marrow-derived macrophages and evidence for serum factors distinct from M-CSF contributing to their propagation in vitro. J Leukoc Biol, 1992. 51(6): p. 525-34.
40. Maruyama, K., et al., Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J
Pathol, 2007. 170(4): p. 1178-91.
41. Wells, C.M., et al., Rac1-deficient macrophages exhibit defects in cell spreading and membrane ruffling but not migration. J Cell Sci, 2004. 117(Pt 7): p. 1259-68.
42. Guo, H., et al., Pivotal Advance: PKCzeta is required for migration of macrophages. J Leukoc Biol, 2009. 85(6): p. 911-8.
43. Nanney, L.B., et al., Calreticulin enhances porcine wound repair by diverse biological effects. Am J Pathol, 2008. 173(3): p. 610-30.
44. Day, C., et al., The chemokine CXCL16 is highly and constitutively expressed by human bronchial epithelial cells. Exp Lung Res, 2009. 35(4): p. 272-83.
45. Don, M.J., et al., Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway. Br J Pharmacol, 2007. 151(5): p. 638-46.
46. Gordillo, G.M., et al., A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation. Am J Physiol Cell Physiol, 2004. 287(4): p.
C866-73.
47. Green, C.E., et al., Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One, 2009. 4(8): p. e6713.
48. Hollingsworth, J.W., et al., CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-stimulated airway disease. Am J Respir Cell Mol Biol, 2007. 37(2): p. 248-53.
49. Ohba, T., et al., A potential role of thymic stromal lymphopoietin in the recruitment of macrophages to mouse intervertebral disc cells via monocyte chemotactic protein 1 induction: implications for herniated discs. Arthritis Rheum, 2008. 58(11): p. 3510-9.
50. Tian, Y., S.E. Kelemen, and M.V. Autieri, Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am J Physiol Cell Physiol, 2006. 290(4): p. C1083-91.
51. Tzang, B.S., et al., Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J Biomed Sci, 2009. 16: p. 13.
52. van der Voort, R., et al., Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum, 2005. 52(5): p. 1381-91.
53. Lee, S.Y. and J.Y. Cho, Inhibitory effects of honokiol on LPS and PMA-stimulated cellular responses of macrophages and monocytes. BMB Rep, 2009. 42(9): p. 574-9.
54. Ward, C., et al., Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than
dendritic cells. Thorax, 2009. 64(5): p. 430-5.
55. Schledzewski, K., et al., Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol, 2006. 209(1): p. 67-77.
|